Kathryn (Kadee) Luderman is the Molecular Pharmacology Highlighted Trainee Author for the October 2018 issue. Dr. Luderman is a postdoctoral fellow with the National Institute of Neurological Disorders and Stroke, National Institutes of Health. Her mentor is David R. Sibley. The Molecular Pharmacology article that earned her selection as a Highlighted Trainee Author is titled “Identification of positive allosteric modulators of the D1 dopamine receptor that act at diverse binding sites” and is available at Molecular Pharmacology.
Dr. Luderman’s area of research is molecular neuropharmacology. She is currently investigating the use of positive allosteric modulators for enhancing the signaling of G protein-coupled receptors, specifically dopamine receptors.
The anticipated impact of Dr. Luderman’s current research is on the development of novel therapeutics for enhancing cognition and memory in disease states involving cognitive decline through a better understanding of how diverse allosteric modulators can affect the activity of dopamine receptors.
When not in the lab, Kadee enjoys running, knitting, and spending time with her husband and daughter. She also volunteers at the Smithsonian National Museum of Natural History.